Three new organotin( iv ) carboxylate compounds were synthesized and structurally characterized by elemental analysis and FT-IR and multinuclear NMR ( 1 H, 13 C, 119 Sn) spectroscopy.
Small molecules with nitrogen-containing scaffolds have gained much attention due to their biological importance in the development of new anticancer agents. The present paper reports the synthesis of a library of new dihydropyridine and pyridine analogs with diverse pharmacophores. All compounds were tested against the human tissue nonspecific alkaline phosphatase (h-TNAP) enzyme. Most of the compounds showed excellent enzyme inhibition against h-TNAP, having IC50 values ranging from 0.49 ± 0.025 to 8.8 ± 0.53 µM, which is multi-fold higher than that of the standard inhibitor (levamisole = 22.65 ± 1.60 µM) of the h-TNAP enzyme. Furthermore, an MTT assay was carried out to evaluate cytotoxicity against the HeLa and MCF-7 cancer cell lines. Among the analogs, the most potent dihydropyridine-based compound 4d was selected to investigate pro-apoptotic behavior. The further analysis demonstrated that compound 4d played a significant role in inducing apoptosis through multiple mechanisms, including overproduction of reactive oxygen species, mitochondrial dysfunction, DNA damaging, and arrest of the cell cycle at the G1 phase by inhibiting CDK4/6. The apoptosis-inducing effect of compound 4d was studied through staining agents, microscopic, and flow cytometry techniques. Detailed structure–activity relationship (SAR) and molecular docking studies were carried out to identify the core structural features responsible for inhibiting the enzymatic activity of the h-TNAP enzyme. Moreover, fluorescence emission studies corroborated the binding interaction of compound 4d with DNA through a fluorescence titration experiment.
13 November 2024 in Journal of Molecular Structure
In our current study, a series of reactions with isolated natural flavonoids (2-phenylchromen-4-one) and flavanone (2,3-dihydro-2-phenylchromen-4-one) through Mannich base was carried out by a one-pot three-component reaction. Their structure-activity relationship study (SAR) reveals the anticancer activity of natural compounds and their Mannich bases. The flavones were substituted by imine at position C-8, while in the flavanones, the reaction takes place at positions C-8 and C-3. Spectroscopic techniques characterized all the isolated and newly synthesized derivatives. Anticancer activity was checked on HeLa and MCF-7 (cancer cell lines) and BHK-21 (normal cell line). Using propidium iodide (PI) and DAPI staining as fluorescence microscopic imaging was confirmed the Apoptotic effect of potent compound. Further, it was evaluated by cell cycle analysis through flow-cytometry, reactive oxygen species and lactate dehydrogenase production. The caspase-9 and -3 activity were estimated by mitochondrial membrane potential. Derivative of naringenin, ((2S)-4′,5,7-Trihydroxyflavan-4-one) where reactions occur at position C-3 were active than others.
1 April 2021 in Anti-Cancer Agents in Medicinal Chemistry
Background and Objective: The growing prevalence of cancer and the resulting chemoresistance exert not only a great healthcare burden but is also a great challenge to public health, worldwide. In search of new chemical entities against cancer, triazine hybrids of stilbene scaffold were investigated for their anticancer potential. Materials and Methods: Synthetic triazine hybrids of stilbene were used for determination of their anticancer potential for cervical (HeLa) and breast (MCF-7) carcinoma cells. Hit compound (7e) namely, sodium (E)-6,6'-(ethene-1,2-diyl)bis(3- ((4-chloro-6-((3-luorophenyl)amino)-1,3,5-triazin-2-yl)amino)benzenesulfonate) was explored further for mechanistic studies. Results: In a set comprised of twelve derivatives, compound, sodium (E)-6,6'-(ethene-1,2-diyl)bis(3-((4-chloro-6-((3- luorophenyl)amino)-1,3,5-triazin-2-yl)amino)benzenesulfonate) (7e) was found most active against HeLa and MCF-7 cells. The present study has revealed that compound 7e may activate mitochondrial pathway of apoptosis in HeLa and MCF-7 cells which was assessed by DNA binding studies, estimation of release of Lactate Dehydrogenase (LDH), fluorescence imaging, production of Reactive Oxygen Species (ROS) in cancer cells, analysis of cell cycle by flow cytometry, change in Mitochondrial Membrane Potential (MMP) and activation of caspase-9 and caspase-3, respectively. Conclusion: Compound 7e may serve as a lead in designing new anticancer compounds from stilbene scaffold.